Crossmark

A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

Crossref DOI link: https://doi.org/10.1038/srep14421

Published Online: 2015-09-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Meihua

Xiang, Rong

Wen, Yuan

Xu, Guangchao

Wang, Chunting

Luo, Shuntao

Yin, Tao

Wei, Xiawei

Shao, Bin

Liu, Ning

Guo, Fuchun

Li, Meng

Zhang, Shuang

Li, Minmin

Ren, Kexing

Wang, Yongsheng

Wei, Yuquan
License Information

Text and Data Mining valid from 2015-09-23

Version of Record valid from 2015-09-23
More Information

Article History

Received: 11 December 2014

Accepted: 19 August 2015

First Online: 23 September 2015

Change Date: 21 September 2020

Change Type: Correction

Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Competing interests

: The authors declare no competing financial interests.

Updates are available Correction dated 2017-10-20

Click to view Correction: https://doi.org/10.1038/srep46841

Updates are available Correction dated 2020-09-21

Click to view Correction: https://doi.org/10.1038/s41598-020-72743-8